Eckardt A - Search Results

1

Phase II multicenter study of the antiepidermal growth factor receptor monoclonal antibody cetuximab in combination with platinum-based chemotherapy in patients with platinum-refractory metastatic and/or recurrent squamous cell carcinoma of the head and neck.

Baselga J, Trigo JM, Bourhis J, Tortochaux J, Cortés-Funes H, Hitt R, Gascón P, Amellal N, Harstrick A, Eckardt A. Baselga J, et al. Among authors: eckardt a. J Clin Oncol. 2005 Aug 20;23(24):5568-77. doi: 10.1200/JCO.2005.07.119. Epub 2005 Jul 11. J Clin Oncol. 2005. PMID: 16009950 Clinical Trial.

2

Targeting EGF-receptor-signalling in squamous cell carcinomas of the head and neck.

Reuter CW, Morgan MA, Eckardt A. Reuter CW, et al. Among authors: eckardt a. Br J Cancer. 2007 Feb 12;96(3):408-16. doi: 10.1038/sj.bjc.6603566. Epub 2007 Jan 16. Br J Cancer. 2007. PMID: 17224925 Free PMC article. Review.

3

Recurrent carcinoma of the head and neck: treatment strategies and survival analysis in a 20-year period.

Eckardt A, Barth EL, Kokemueller H, Wegener G. Eckardt A, et al. Oral Oncol. 2004 Apr;40(4):427-32. doi: 10.1016/j.oraloncology.2003.09.019. Oral Oncol. 2004. PMID: 14969822

4

Preoperative paclitaxel/carboplatin radiochemotherapy for stage III/IV resectable oral and oropharyngeal cancer: seven-year follow-up of a phase II trial.

Eckardt A, Sinikovic B, Hofele C, Bremer M, Reuter C. Eckardt A, et al. Oncology. 2007;73(3-4):198-203. doi: 10.1159/000127420. Epub 2008 Apr 17. Oncology. 2007. PMID: 18424883 Clinical Trial.

5

Re-irradiation of head and neck cancer-impact of total dose on outcome.

Janssen S, Baumgartner M, Bremer M, Warszawski A, Stieve M, Eckardt A, Karstens JH, Meyer A. Janssen S, et al. Among authors: eckardt a. Anticancer Res. 2010 Sep;30(9):3781-6. Anticancer Res. 2010. PMID: 20944169

6

Palliative intra-arterial (i.a.) chemotherapy with carboplatin (CBDCA) and 5-FU in unresectable advanced (stage III and IV) head and neck cancer using implantable port-systems.

Eckardt A, Kelber A, Pytlik C. Eckardt A, et al. Eur J Surg Oncol. 1995 Oct;21(5):486-9. doi: 10.1016/s0748-7983(95)96824-5. Eur J Surg Oncol. 1995. PMID: 7589591 Clinical Trial.

7

Impact of Time Factors on Outcome in Patients with Head and Neck Cancer Treated with Definitive Radio(Chemo)Therapy.

Dahlke S, Steinmann D, Christiansen H, Durisin M, Eckardt A, Wegener G, Bremer M, Meyer A. Dahlke S, et al. Among authors: eckardt a. In Vivo. 2017 Sep-Oct;31(5):949-955. doi: 10.21873/invivo.11152. In Vivo. 2017. PMID: 28882964 Free PMC article.

8

International collaborative validation of intraneural invasion as a prognostic marker in adenoid cystic carcinoma of the head and neck.

Amit M, Binenbaum Y, Trejo-Leider L, Sharma K, Ramer N, Ramer I, Agbetoba A, Miles B, Yang X, Lei D, Bjørndal K, Godballe C, Mücke T, Wolff KD, Eckardt AM, Copelli C, Sesenna E, Palmer F, Ganly I, Patel S, Gil Z. Amit M, et al. Among authors: eckardt am. Head Neck. 2015 Jul;37(7):1038-45. doi: 10.1002/hed.23710. Epub 2014 Jul 24. Head Neck. 2015. PMID: 24710845

9

Palliative, intraarterial chemotherapy for advanced head and neck cancer using an implantable port system.

Eckardt A, Kelber A. Eckardt A, et al. J Oral Maxillofac Surg. 1994 Dec;52(12):1243-6. doi: 10.1016/0278-2391(94)90044-2. J Oral Maxillofac Surg. 1994. PMID: 7525905

10

Role of human papillomavirus infection and other factors in patients with head and neck squamous cell carcinoma.

Iqbal A, Warraich R, Udeabor SE, Rana M, Eckardt AM, Gellrich NC, Rana M. Iqbal A, et al. Among authors: eckardt am. Oral Dis. 2014 Apr;20(3):288-93. doi: 10.1111/odi.12110. Epub 2013 Apr 17. Oral Dis. 2014. PMID: 23590799

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

299 results

Search Page

Filters